Literature DB >> 35779086

Paraneoplastic syndrome in neuroophthalmology.

Longdan Kang1, Chao Wan2.   

Abstract

Paraneoplastic syndrome is a group of clinical symptoms that occur in the state of systemic malignant tumors. Paraneoplastic syndrome of the nervous system can affect any part of the central and peripheral nervous system and may also affect the eyes. In neuroophthalmology, paraneoplastic syndrome has a variety of manifestations that can affect both the afferent and efferent visual systems. The afferent system may involve the optic nerve, retina and uvea; the efferent system may involve eye movement, neuromuscular joints or involuntary eye movements and pupil abnormalities and may also have other neurological symptoms outside the visual system. This article discusses the clinical manifestations, pathological mechanisms, detection methods and treatment methods of paraneoplastic syndrome in neuroophthalmology. The performance of paraneoplastic syndrome is diverse, the diagnosis is difficult, and the treatment should be considered systematically. Differential diagnosis, optimal evaluation and management of these manifestations is not only the key to treatment but also a challenge.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Cancer-associated retinopathy; Lambert-Eaton myasthenic syndrome; Melanoma-associated retinopathy; Neuroophthalmology; Opsoclonus-myoclonus syndrome; Paraneoplastic syndrome

Mesh:

Year:  2022        PMID: 35779086     DOI: 10.1007/s00415-022-11247-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   6.682


  88 in total

Review 1.  Paraneoplastic endocrine syndromes.

Authors:  Georgios K Dimitriadis; Anna Angelousi; Martin O Weickert; Harpal S Randeva; Gregory Kaltsas; Ashley Grossman
Journal:  Endocr Relat Cancer       Date:  2017-03-24       Impact factor: 5.678

2.  Immunophenotypical characterization of paraneoplastic neurological syndrome patients: a multicentric study.

Authors:  Lorenzo Lorusso; Vincenza Precone; Ian K Hart; Bruno Giometto; Raffaele Pezzani; Gaelle K Ngonga; Gaelle K Ngonga K Ngonga; Stefano Paolacci; Daniela Ferrari; Giovanni Ricevuti; Ernie Marshall; Matteo Bertelli
Journal:  J Biosci       Date:  2021       Impact factor: 1.826

Review 3.  Updates in the Diagnosis and Treatment of Paraneoplastic Neurologic Syndromes.

Authors:  Ronnyson Susano Grativvol; Wagner Cid Palmeira Cavalcante; Luiz Henrique Martins Castro; Ricardo Nitrini; Mateus Mistieri Simabukuro
Journal:  Curr Oncol Rep       Date:  2018-11-10       Impact factor: 5.075

4.  Blindness caused by photoreceptor degeneration as a remote effect of cancer.

Authors:  R A Sawyer; J B Selhorst; L E Zimmerman; W F Hoyt
Journal:  Am J Ophthalmol       Date:  1976-05       Impact factor: 5.258

Review 5.  Paraneoplastic neuropathies.

Authors:  Jean-Christophe Antoine; Jean-Philippe Camdessanché
Journal:  Curr Opin Neurol       Date:  2017-10       Impact factor: 5.710

6.  Does the Tempo and Pattern of Neurological Syndrome Help Diagnose Paraneoplastic Etiology?

Authors:  Pawan Ojha; Kamlesh Jagiasi; Akash Chheda; Girish Soni; Dhanashree Peddawad; Nikhil Kadam; Sarika Patil
Journal:  J Assoc Physicians India       Date:  2018-09

7.  Cancer-associated retinopathy preceding the diagnosis of cancer.

Authors:  Florence Hoogewoud; Pauline Butori; Philippe Blanche; Antoine P Brézin
Journal:  BMC Ophthalmol       Date:  2018-11-03       Impact factor: 2.209

8.  Case Series of Cancer-associated Retinopathy (CAR).

Authors:  Srikanth Naramala; Jowairiyya Ahmad; Sreedhar Adapa; Frank Gavini; Venu Madhav Konala
Journal:  Cureus       Date:  2019-06-10

Review 9.  Ocular Paraneoplastic Syndromes.

Authors:  Joanna Przeździecka-Dołyk; Anna Brzecka; Maria Ejma; Marta Misiuk-Hojło; Luis Fernando Torres Solis; Arturo Solís Herrera; Siva G Somasundaram; Cecil E Kirkland; Gjumrakch Aliev
Journal:  Biomedicines       Date:  2020-11-10

10.  Paraneoplastic autoimmune multiorgan syndrome.

Authors:  Dario Didona; Giovanni DI Zenzo; Pascal Joly
Journal:  Ital J Dermatol Venerol       Date:  2020-10-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.